A world free from cancers: Probable, possible, or preposterous?

Leading experts focus on the challenges and opportunities affecting the fight against cancer

2014-02-27

(Press-News.org) ALEXANDRIA, Va. – February 27, 2014 – A panel of leading health, economics and policy experts today discussed the prospects for a future where cancers are rendered manageable or even eradicated and the variables affecting progress toward that goal so that cancer patients are able to lead normal, productive lives – and thus be "free from" their cancers. The forum was hosted by Research!America and the Pancreatic Cancer Action Network. The event, titled, "A World Free from Cancers: Probable, Possible, or Preposterous?" was held at the New York Academy of Sciences.

Medical innovation has contributed to the economic success of the U.S. over the last 50 years and it offers enormous potential to make a meaningful difference in the quality and length of our lives in the next 50 years. Of all the critical trends that will create a prosperous future, the panelists believe that medical innovation will be the most important. In order to achive a culture of change where science and medicine will be part of the solution, all stakeholders must stand up and advocate for pro-patient and pro-innovation policies and laws. By supporting a positive regulatory and legislative environment and working toward innovative solutions for complex healthcare challenges, policy makers can help combat devastating diseases like cancers.

"While medical innovation has driven extraordinary progress against cancer in the U.S. and peer nations, we know that globally, cancer cases and death rates are rising. And even in the U.S., the incidence of some cancers, including pancreatic cancer, is rising," said Mary Woolley, president and CEO, Research!America. "We need to work together to address these alarming trends, and commit to overcoming the barriers to achieving a world free from cancers. Ensuring that U.S. policymakers sustain a policy environment conducive to rapid-pace medical innovation is crucial."

The panel addressed the role of medical innovation, not only in the fight against cancer, but as a major force in our nation's economic progress. Among the technological advances of the 21st century, medical innovation has been the biggest factor in improving the lives of patients, benefiting the healthcare system and improving prosperity. Over the past 50 years, medical innovation has been the source of more than half of all economic growth in the United States.

The panel, moderated by Fox News Channel's Jim Pinkerton, featured several leading figures in the cancer and healthcare community, including:

Clifton Leaf, journalist and author, "The Truth in Small Doses: Why We're Losing the War on Cancer-and How to Win It"

Julie Fleshman, president and CEO, Pancreatic Cancer Action Network

Laurie MacCaskill, seven-year pancreatic cancer survivor and chair, national Board of Directors, Pancreatic Cancer Action Network

Amy Abernethy, MD, PhD, director, Duke Center for Learning Healthcare

Robert J. Hariri, MD, PhD, chairman, founder and chief scientific officer, Celgene Cellular Therapeutics

Scott Gottlieb, MD, resident fellow, American Enterprise Institute

Frank Lichtenberg, PhD, Courtney C. Brown Professor of Business, Columbia University

"Although medical innovation has played a key role in the fight against cancer and improving the overall cancer survival rate, much work lies ahead especially for deadly cancers such as pancreatic cancer where the five-year survival rate is just six percent," said Julie Fleshman, president and CEO, Pancreatic Cancer Action Network. "In order to move towards a world free from cancers, the cancer infrastructure has to continue to keep up with the advances in science and our nation needs to make medical research a priority."

The panel discussed the benefits of past breakthroughs for some types of cancer: there have been an estimated 50 million life-years saved and $4.9 trillion added in economic value due to innovative cancer treatments since 1990. However, further success in reducing the devastating impacts of cancers and accelerating medical innovation is dependent on developing effective collaborative solutions from an "ecosystem of innovation" – bringing together scientists, patients, healthcare providers, private-sector medical innovators, academia, payers and policymakers – to find solutions that will save lives from all types of cancers.

"We have made great progress since 1971, when President Nixon declared the war on cancer, in terms of understanding the epidemiology of the disease, improving diagnoses, discovering new treatment paradigms and novel therapeutic approaches to better manage cancers," said Robert Hariri, MD, PhD, chairman, founder and chief scientific officer, Celgene Cellular Therapeutics. "But the progress we've made is not enough. We need to continue the momentum we have started and work together to change the course of human health for patients, healthcare, our economy and future generations."

INFORMATION: About Research!America

Research!America is the nation's largest nonprofit public education and advocacy alliance working to make research to improve health a higher national priority. Founded in 1989, Research!America is supported by member organizations representing 125 million Americans. Visit http://www.researchamerica.org.

About the Pancreatic Cancer Action Network

The Pancreatic Cancer Action Network is the national organization creating hope in a comprehensive way through research, patient support, community outreach and advocacy for a cure. The organization is leading the way to change the survival for people diagnosed with this devastating disease through a bold initiative — The Vision of Progress: Double Survival for Pancreatic Cancer Survival by 2020. Together, we can know, fight and end pancreatic cancer by intensifying our efforts to heighten awareness, raise funds for comprehensive private research, and advocate for dedicated federal research to advance early diagnostics, better treatments and increase chances of survival. To learn more, visit http://www.pancan.org.

Contacts:

Research!America
Suzanne Ffolkes
VP, Communications
Direct: 571-482-2710
sffolkes@researchamerica.org

Pancreatic Cancer Action Network
Jennifer Reeves Rosen
Senior Manager, Public Relations
Direct: 310-706-3362
jrosen@pancan.org

ELSE PRESS RELEASES FROM THIS DATE:

Math anxiety factors into understanding genetically modified food messages

2014-02-27

People who feel intimidated by math may be less able to understand messages about genetically modified foods and other health-related information, according to researchers. "Math anxiety, which happens when people are worried or are concerned about using math or statistics, leads to less effort and decreases the ability to do math," said Roxanne Parrott, Distinguished Professor of Communication Arts and Sciences and Health Policy and Administration. "Math anxiety also has been found to impair working memory." The researchers found that math anxiety led to a decrease ...

Google Glass could help stop emerging public health threats around the world

2014-02-27

The much-talked-about Google Glass — the eyewear with computer capabilities — could potentially save lives, especially in isolated or far-flung locations, say scientists. They are reporting development of a Google Glass app that takes a picture of a diagnostic test strip and sends the data to computers, which then rapidly beam back a diagnostic report to the user. The information also could help researchers track the spread of diseases around the world. The study appears in the journal ACS Nano, a publication of the American Chemical Society, the world's largest scientific ...

Faster anthrax detection could speed bioterror response

2014-02-27

COLUMBIA, Mo. – Shortly following the 9/11 terror attack in 2001, letters containing anthrax spores were mailed to news outlets and government buildings killing five people and infecting 17 others. According to a 2012 report, the bioterrorism event cost $3.2 million in cleanup and decontamination. At the time, no testing system was in place that officials could use to screen the letters. Currently, first responders have tests that can provide a screen for dangerous materials in about 24-48 hours. Now, researchers at the University of Missouri have worked with a private ...

Montreal researchers find a link between pollutants and certain complications of obesity

2014-02-27

Montréal, February 27, 2014 – A team of researchers at the IRCM in Montréal led by Rémi Rabasa-Lhoret, in collaboration with Jérôme Ruzzin from the University of Bergen in Norway, found a link between a type of pollutants and certain metabolic complications of obesity. Their breakthrough, published online this week by the Journal of Clinical Endocrinology & Metabolism, could eventually help improve the prevention, diagnosis, and treatment of cardiometabolic risk associated with obesity, such as diabetes, hypertension and cardiovascular disease. Although obesity is strongly ...

Battery-free technology brings gesture recognition to all devices

2014-02-27

Mute the song playing on your smartphone in your pocket by flicking your index finger in the air, or pause your "This American Life" podcast with a small wave of the hand. This kind of gesture control for electronics could soon become an alternative to touchscreens and sensing technologies that consume a lot of power and only work when users can see their smartphones and tablets. University of Washington computer scientists have built a low-cost gesture recognition system that runs without batteries and lets users control their electronic devices hidden from sight with ...

Bisphenol A (BPA) at very low levels can adversely affect developing organs in primates

2014-02-27

COLUMBIA, Mo. – Bisphenol A (BPA) is a chemical that is used in a wide variety of consumer products, such as resins used to line metal food and beverage containers, thermal paper store receipts, and dental composites. BPA exhibits hormone-like properties, and exposure of fetuses, infants, children or adults to the chemical has been shown to cause numerous abnormalities, including cancer, as well as reproductive, immune and brain-behavior problems in rodents. Now, researchers at the University of Missouri have determined that daily exposure to very low concentrations of ...

Household wealth still down 14 percent since recession

2014-02-27

COLUMBUS, Ohio – Household wealth for Americans still has not recovered from the recession, despite last summer's optimistic report from the U.S. Federal Reserve, a new study suggests. Economists at The Ohio State University found that the mean net worth of American households in mid-2013 was still about 14 percent below the pre-recession peak in 2006. Their analysis suggested that middle-aged people took the biggest hit. In a report last June, the Federal Reserve said that net worth of Americans – which includes the value of homes, stocks and other assets minus debts ...

IUPUI study reveals how dogs detect explosives, offers new training recommendations

2014-02-27

INDIANAPOLIS— A research team at Indiana University-Purdue University Indianapolis (IUPUI) has helped determine the science behind how canines locate explosives such as Composition C-4 (a plastic explosive used by the U.S. military). The study found the dogs react best to the actual explosive, calling into question the use of products designed to mimic the odor of C-4 for training purposes. These findings are the culmination of a four-year contract funded by the U.S. Department of Defense (DOD). "Appropriately, dogs that are trained to find real explosives are going ...

Type 1 diabetes: Vitamin D deficiency occurs in an early stage

2014-02-27

Vitamin D is known as a major regulator of calcium levels and bone metabolism. Furthermore, it also influences the immune system. Previous studies have shown that patients with recently diagnosed type 1 diabetes have significantly lower vitamin D levels. Scientists from the Institute of Diabetes Research (IDF) and the Helmholtz Zentrum München, a member of the German Center for Diabetes Research (DZD), as well as from the Diabetes Research Group at the Technische Universität München (TUM) examined whether a vitamin D deficiency occurs during an early stage of type 1 diabetes, ...

Scientists learn how pathogens hack our immune systems to go undetected

2014-02-27

A new report appearing in the March 2014 issue of The FASEB Journal helps shed light on what drives the evolution of pathogens, as well as how our bodies adapt to ward them off. Specifically, the report shows that our bodies naturally employ a mechanism, called "CD33rSiglecs," that not only dampens unwanted immune responses against one's own cells, but also evolves rapidly to recognize foreign invaders. What's more, the report explains how pathogens exploit this immunological "vulnerability" of "self-recognition" to evade our bodies' defenses. This leads to a seemingly ...

Catheter-directed mechanical thrombectomy system demonstrates safety and effectiveness in patients with pulmonary embolism

Novel thrombectomy system demonstrates positive safety and feasibility results in treating acute pulmonary embolism

Biomimetic transcatheter aortic heart valve offers new option for aortic stenosis patients

SMART trial reaffirms hemodynamic superiority of TAVR self-expanding valve in aortic stenosis patients with a small annulus over time and regardless of age

Metastatic prostate cancer research: PSMAfore follow-on study favors radioligand therapy over change to androgen receptor pathway inhibition

Studies highlight need for tailored treatment options for women with peripheral artery disease

Women and Black patients less likely to receive catheter-based treatment for pulmonary embolism

[Press-News.org] A world free from cancers: Probable, possible, or preposterous?
Leading experts focus on the challenges and opportunities affecting the fight against cancer

A world free from cancers: Probable, possible, or preposterous?

ELSE PRESS RELEASES FROM THIS DATE:

LAST 30 PRESS RELEASES: